HMOX1 and breast cancer: In BC with such characteristics, extracellular matrix metalloproteinases (MMPs), critical regulators of the metastatic process, are often overexpressed, and fisetin can affect the downregulation of MMP-2/9 enzymes by the multifunctional nuclear regulator Nrf2 and heme oxygenase 1 (HO-1) [56].